Visual Outcome, Treatment Results, and Prognostic Factors in Patients with Scleritis
- 1 February 2013
- journal article
- Published by Elsevier BV in Ophthalmology
- Vol. 120 (2), 379-386
- https://doi.org/10.1016/j.ophtha.2012.08.005
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Rituximab Treatment for Persistent Scleritis Associated with Rheumatoid ArthritisOcular Immunology and Inflammation, 2010
- Infliximab for the treatment of refractory scleritisBritish Journal of Ophthalmology, 2009
- Rituximab for treatment of scleritis associated with rheumatoid arthritisBritish Journal of Ophthalmology, 2009
- Therapy Insight: scleritis and its relationship to systemic autoimmune diseaseNature Clinical Practice Rheumatology, 2007
- ScleritisSurvey of Ophthalmology, 2005
- Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritisOphthalmology, 2004
- Prediction of response to treatment in patients with scleritis using a standardised scoring systemAustralian and New Zealand Journal of Ophthalmology, 1991
- Progression of Scleral DiseaseOphthalmology, 1991
- Inflammation of the ScleraInternational Ophthalmology Clinics, 1983
- Scleritis and episcleritis.British Journal of Ophthalmology, 1976